These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2339628)

  • 21. [Fluoride in osteoporosis: still an experimental and controversial treatment].
    Lips P
    Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1913-5. PubMed ID: 9856177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The microscopic morphology of fluoride-induced bone.
    Vigorita VJ; Suda MK
    Clin Orthop Relat Res; 1983; (177):274-82. PubMed ID: 6407795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate.
    Ringe JD; Dorst A; Kipshoven C; Rovati LC; Setnikar I
    Osteoporos Int; 1998; 8(1):47-52. PubMed ID: 9692077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of long-term treatment of primary osteoporosis with sodium fluoride (author's transl)].
    Kruse HP; Kuhlencordt F; Ringe JD
    Dtsch Med Wochenschr; 1978 Feb; 103(6):248-52. PubMed ID: 627182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone complications during the treatment of osteoporosis with fluor].
    Marcelli C; Pansard E; Thomas E; Hérisson C; Simon L
    Rev Med Interne; 1989; 10(2):118-26. PubMed ID: 2740660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trabecular stress fractures during fluoride therapy for osteoporosis.
    Schnitzler CM; Solomon L
    Skeletal Radiol; 1985; 14(4):276-9. PubMed ID: 4071102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of acute lower extremity pain syndrome in fluoride-treated osteoporotic patients.
    O'Duffy JD; Wahner HW; O'Fallon WM; Johnson KA; Muhs JM; Beabout JW; Hodgson SF; Riggs BL
    Am J Med; 1986 Apr; 80(4):561-6. PubMed ID: 3963037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term fluoride therapy of postmenopausal osteoporosis.
    Dambacher MA; Ittner J; Ruegsegger P
    Bone; 1986; 7(3):199-205. PubMed ID: 3768198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosis.
    Murray TM; Ste-Marie LG
    CMAJ; 1996 Oct; 155(7):949-54. PubMed ID: 8837545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supraacetabular and femoral head stress fracture during fluoride treatment.
    van Linthoudt D; Ott H
    Gerontology; 1987; 33(5):302-6. PubMed ID: 3678845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sodium fluoride, inorganic phosphate, and oxymetholone therapies in osteoporosis: a six-year progress report.
    Vose GP; Keele DK; Milner AM; Rawley R; Roach TL; Sprinkle EE
    J Gerontol; 1978 Mar; 33(2):204-12. PubMed ID: 627704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.
    Alexandersen P; Riis BJ; Christiansen C
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3013-20. PubMed ID: 10487657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of hip fractures in osteoporotic women treated with sodium fluoride.
    Riggs BL; Baylink DJ; Kleerekoper M; Lane JM; Melton LJ; Meunier PJ
    J Bone Miner Res; 1987 Apr; 2(2):123-6. PubMed ID: 3455161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoride therapy of type I osteoporosis.
    Devogelaer JP; Nagant de Deuxchaisnes C
    Clin Rheumatol; 1995 Sep; 14 Suppl 3():26-31. PubMed ID: 8846658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fractures caused by bone insufficiency in osteoporotic patients treated with sodium fluoride].
    Gaucher A; Péré P; Bannwarth B; Gillet P
    Presse Med; 1987 Jun; 16(21):1059. PubMed ID: 2955336
    [No Abstract]   [Full Text] [Related]  

  • 36. [Stress fractures during fluoride therapy. Physiopathological value of histomorphometry].
    Toussirot E; Schiano A; Lafforgue P; Acquaviva PC; Roux H
    Rev Rhum Mal Osteoartic; 1991 Oct; 58(9):571-5. PubMed ID: 1775903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of bone fluoride determination in osteoporotic patients treated with sodium fluoride].
    Laurent V; de Vernejoul MC; Brouard A; Terrier JL; Miravet L; Kuntz D
    Presse Med; 1989 Apr; 18(13):679-82. PubMed ID: 2524040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of common osteoporosis with fluoride: current trends].
    Kuntz D
    Rev Rhum Mal Osteoartic; 1992 Jan; 59(1):39-45. PubMed ID: 1579845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence.
    Riggs BL; Hodgson SF; Hoffman DL; Kelly PJ; Johnson KA; Taves D
    JAMA; 1980 Feb; 243(5):446-9. PubMed ID: 7351765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro.
    Marie PJ; De Vernejoul MC; Lomri A
    J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.